Impact related activities
Development of compact X-ray imaging device
A collaboration with a UK based SME supported the development of a new compact 3D X-ray imaging device. Joint research focussed on detailed studies into image resolution and 4D imaging capabilities.
Deployment of the SIGMA detector to track gamma-rays back to their point of origin
In collaboration with Mirion, researchers in the Department of Physics evaluated the performance of SIGMA when imaging gamma-ray sources are present in industrial waste streams.
Thin solid state dosimeter charge integrator for proton beams for cancer therapy treatment
In collaboration with a proton therapy partner, researchers in the Particle Physics Group developed a prototype which potentially provides a low-cost, high resolution alternative to the complex and expensive ionization chambers currently available.
Thermal neutron detector
Researchers in Particle Physics developed a proof of concept project to improve the efficiency of a thermal neutron detector based on silicon. Our industry partner used the results to enhance the development of their detectors for the nuclear industry.
Applications of a Digital Micro-mirror Device (DMD) to novel particle accelerator diagnostics
This project targeted commercially viable DMD-based diagnostics, which have the potential for development into diagnostic products alongside our industrial partner, D-Beam Ltd.
3D printed, composite structures with integrated electronics
In collaboration with Sensor City, researchers in Particle Physics studied the production of simple 3D-printed phantoms with built-in circuitry and sensing elements. Further investigations will examine how this new type of compact phantom can potentially be used in hadron therapy.
Next generation Particle Accelerator diagnostics
Researchers in the Liverpool Accelerator Physics QUASAR Group collaborated with the company D-Beam Ltd in commercialising R&D using state of the art technology from the upgrade of the Large Hadron Collider at CERN. This produced innovative product solutions for the accelerator, healthcare and security sectors. Particle accelerators drive the development of new medicines, treat cancer, and improve progress in chemistry and environmental sciences. Developing novel diagnostic solutions for accelerator and clinical facilities, increases their output, reliability and cost efficiency.
Improved Treatment of Retinal Detachments Using Novel Tamponade Agents
In collaboration with industry partners and clinicians, academic researchers developed and commercialised novel silicone oil tamponades which delivered improved surgical treatment of retinal detachments, resulting in significant impacts on health and wellbeing.